Remus PharmaceuticalsNSE:REMUS +0.59%55 Dividend Yield % is 0.13% as of Jun. 25, 2026, which is 30% above its 10-year median of 0.10. GuruFocus rates NSE:REMUS with a GF Score™ of 55/100 and a GF Value™ of ₹2,071.36 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, Remus Pharmaceuticals ranks worse than 100% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Remus Pharmaceuticals is 0.13%.
The historical rank and industry rank for Remus Pharmaceuticals's Dividend Yield % or its related term are showing as below:
NSE:REMUS'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.04 Med: 0.1 Max: 0.16
Current: 0.13
During the past 7 years, the highest Dividend Yield of Remus Pharmaceuticals was 0.16%. The lowest was 0.04%. And the median was 0.10%.
NSE:REMUS's Dividend Yield % is ranked worse than 100% of 69
companies
in the Medical Distribution industry
Industry Median: 2.91
vs NSE:REMUS: 0.13
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Remus Pharmaceuticals Dividend Yield % Related Terms
Remus Pharmaceuticals Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Remus Pharmaceuticals's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:REMUS vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Remus Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Remus Pharmaceuticals Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Remus Pharmaceuticals's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Remus Pharmaceuticals Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 0.500000
2025-11-14
2025-11-14
0000-00-00
Cash Dividend
semi-annually
INR:INR 1.000000
INR 0.500000
2025-09-18
2025-09-18
0000-00-00
Cash Dividend
semi-annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Remus Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Remus Pharmaceuticals (NSE:REMUS) has a Dividend Yield % of 0.13% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Remus Pharmaceuticals and its competitors. This is 30% above median its historical median of 0.10. Over the past decade, Remus Pharmaceuticals' Dividend Yield % has ranged from 0.04 to 0.16. According to the industry distribution chart, Remus Pharmaceuticals ranks #69 out of 69 companies in the Medical Distribution industry.
Is Remus Pharmaceuticals' Dividend Yield % too high?
Remus Pharmaceuticals' current Dividend Yield % of 0.13% is 30% above median its 10-year median of 0.10. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.16. The Medical Distribution industry median Dividend Yield % is 2.91. Remus Pharmaceuticals' value of 0.13% is 95.5% below this industry median. Based on the distribution chart, Remus Pharmaceuticals ranks #69 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Remus Pharmaceuticals has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Remus Pharmaceuticals' Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Remus Pharmaceuticals ranks #69 out of 69 companies for Dividend Yield %. This places Remus Pharmaceuticals in the lower half of its industry. The industry median Dividend Yield % is 2.91. Remus Pharmaceuticals' value of 0.13% is 95.5% below this benchmark. Historically, Remus Pharmaceuticals' own Dividend Yield % has ranged from 0.04 to 0.16 over the past decade. While the company's 10-year median is 0.10 vs. the industry median of 2.91, Remus Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.91, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Remus Pharmaceuticals's current Dividend Yield % of 0.13% is 95.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Remus Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Remus Pharmaceuticals's current Dividend Yield % is 0.13%, which is 30% above median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Remus Pharmaceuticals (NSE:REMUS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹2,071.36, compared to a current price of ₹801.85 — trading 61.3% below its estimated fair value. The current Dividend Yield % is 0.13%, which is 30% above median its 10-year median of 0.10 and 95.5% below the Medical Distribution industry median of 2.91. Remus Pharmaceuticals' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Remus Pharmaceuticals (NSE:REMUS), the current Dividend Yield % is 0.13% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Remus Pharmaceuticals (NSE:REMUS) Overvalued in 2026?
Based on GuruFocus' analysis, Remus Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹801.85 is trading 61.3% below its estimated GF Value™ of ₹2,071.36.
GuruFocus considers Remus Pharmaceuticals to be Significantly Undervalued.
Key valuation signals for NSE:REMUS:
Dividend Yield %: 0.13% (30% above median its 10-year median of 0.10)
GF Value™: ₹2,071.36 vs. price of ₹801.85 (61.3% below fair value)
Industry Position: 95.5% below the Medical Distribution median (#69 of 69)
No single metric tells the full story. See the NSE:REMUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.
55GF Score
Get the complete analysis for NSE:REMUS
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:REMUS has been successfully added to your 
